Advanced Weight Loss
Tirzepatide
Starting at $299/month*
A dual-action therapy for advanced weight loss, helping quiet cravings and support metabolic health through two complementary pathways.
- Powerful appetite control
- Significant, lasting results
- Better metabolic health
- Licensed-provider care, shipped discreetly
*Price reflects the longest available treatment plan. Prescription therapies require an online consultation and licensed-provider approval.
How It Works
Tirzepatide is a dual GIP and GLP-1 receptor agonist, engaging two complementary appetite and metabolic pathways at once. Administered weekly under provider supervision, it helps reduce appetite, quiet cravings, and support advanced weight loss.
Discovery & Testing Background
Tirzepatide builds on GLP-1 research by adding GIP activity, and has been studied in large clinical trials for both glucose control and weight management. It represents a newer generation of dual-pathway metabolic therapy.
Potential Side Effects
Side effects are most often gastrointestinal — nausea, reduced appetite, or digestive upset — and typically lessen with gradual dose increases under provider guidance.
Tirzepatide Benefits
Function: By activating both GIP and GLP-1 receptors, tirzepatide influences appetite, insulin response, and energy balance more comprehensively than single-pathway therapies.
Benefit: This dual action is associated with significant, provider-guided weight loss and improved metabolic health when combined with lifestyle support.
